On Sept. 5, 2019, Stephen Doberstein – SVP and Chief Scientific Officer of Nektar Therapeutics (NKTR) – purchased 15,000 shares of NKTR at $17.28. His out of pocket cost was $259,200.
Insider Buying in Nektar Therapeutics (NKTR)
FREE GIFT for signing up: Jesse Livermore's Book "How to Trade in Stocks" (Value $20.12 on Amazon). Livermore made $100,000,000 trading his own personal account during the Great Depression (inflation adjusted, a record that has never been topped).
100% privacy. No email sharing. No spam.
